Nephrotic Stndrome - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased glomerular permeability - In nephrotic syndrome, the kidneys' filtering units (glomeruli) become damaged, allowing proteins like albumin to leak into the urine, leading to low blood protein levels and fluid imbalance.

• Secondary mechanism: Loss of plasma oncotic pressure - As proteins are lost in the urine, the blood's ability to retain fluid within the vessels decreases, causing fluid to leak into tissues and resulting in edema, especially in the legs, ankles, and around the eyes.

• Key complication: Hyperlipidemia - The liver increases production of lipoproteins in response to low blood protein levels, leading to elevated cholesterol and triglyceride levels, which may increase the risk of cardiovascular disease.

Patient Profile

Demographics:

12-year-old male, student

History:

• Key past medical history: Mild seasonal allergies

• Current medications: None

• Allergies: Allergic to penicillin

Current Presentation:

• Chief complaint: Swelling in ankles

• Key symptoms: Mild puffiness around eyes, slight frothy urine

• Vital signs: Blood pressure 110/70 mmHg, heart rate 75 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

Initial assessment findings reveal that the 12-year-old male's swelling is predominantly noticeable in the periorbital area and ankles, consistent with edema related to nephrotic syndrome. Upon physical examination, the skin appears slightly pale and puffy, but there are no signs of dehydration or significant distress. The child reports feeling generally well, aside from the discomfort associated with swelling. A urine dipstick test shows 3+ proteinuria, which corroborates the suspected diagnosis of nephrotic syndrome. There are no signs of hematuria or infection, and the child's urine output remains within normal limits for his age.

To further assess the condition, the medical team orders a basic metabolic panel and lipid profile. The serum albumin level is low at 2.8 g/dL, confirming hypoalbuminemia, while the cholesterol level is elevated at 280 mg/dL, indicative of hyperlipidemia. Electrolyte levels are within normal ranges, and renal function tests, including serum creatinine and blood urea nitrogen (BUN), are normal. These findings suggest that the kidneys' filtering capacity is affected but not severely compromised at this early stage. The child's blood pressure remains stable at 110/70 mmHg.

These assessment findings support the diagnosis of stable, early-stage nephrotic syndrome with minor complications. The focus of nursing care will include monitoring fluid status, providing education on dietary modifications to manage hyperlipidemia, and emphasizing the importance of follow-up appointments to monitor the progression of the condition. The team will also evaluate the need for initiating corticosteroid therapy as a standard treatment to help reduce proteinuria and control symptoms. The child and his family are reassured about the generally favorable prognosis with appropriate management and are encouraged to maintain regular communication with the healthcare team.

Section 2

The medical team decides to initiate corticosteroid therapy to manage the child's proteinuria and control the symptoms of nephrotic syndrome. Prednisone is prescribed, and the nursing team provides education to the family on the importance of adhering to the medication regimen, potential side effects, and the necessity of monitoring the child's response to the treatment. The family is advised to watch for any signs of infection, as immunosuppression is a known side effect of corticosteroid use. They are also informed about the importance of a low-sodium diet to help manage the child's edema.

After two weeks of corticosteroid therapy, the child returns for a follow-up appointment. During this visit, his mother reports noticing a slight reduction in the swelling of his ankles and around his eyes. The child continues to feel generally well and has had no significant adverse reactions to the medication. A repeat urine dipstick test shows a decrease in proteinuria to 1+, indicating a positive response to the treatment. The child's serum albumin level has improved slightly to 3.2 g/dL, and his cholesterol level has decreased to 250 mg/dL, suggesting that the dietary modifications and medication are having a beneficial effect.

The nursing team conducts a thorough physical assessment, noting that the child's skin appears less puffy and his overall appearance is healthier. His vital signs remain stable with a blood pressure of 108/68 mmHg and a heart rate of 78 beats per minute. The child's weight has stabilized, and his urine output continues to be within normal limits. The clinical team is encouraged by these positive changes and schedules another follow-up in a month to continue monitoring the child's progress and adjust the treatment plan as necessary. The family is reassured that with continued compliance to the treatment and lifestyle recommendations, the prognosis remains favorable.

Section 3

During the subsequent follow-up visit, the nursing team notes further improvement in the child's condition, indicating a positive response to the ongoing treatment plan. The child's mother reports that the edema has diminished significantly, with only minimal swelling around the ankles remaining. The child continues to engage in regular activities and displays a good energy level. The nursing staff conducts a detailed physical assessment and observes that the child's skin turgor has returned to normal, and his facial features appear more defined, reflecting a reduction in fluid retention.

The clinical team reviews the latest laboratory results, which show continued progress. The urine dipstick test reveals only trace amounts of proteinuria, suggesting a further improvement in kidney function. The child's serum albumin level has increased to 3.5 g/dL, indicating better nutritional status and protein retention. Additionally, his cholesterol level has declined to 220 mg/dL, a sign that the dietary modifications and corticosteroid therapy are effectively managing the condition. The child's vital signs remain stable, with a blood pressure of 106/66 mmHg and a heart rate of 76 beats per minute, reinforcing the positive trend in his recovery.

Given these encouraging findings, the healthcare team decides to gradually taper the corticosteroid dosage, while maintaining close monitoring to ensure the child's continued stability. The family is advised to persist with the low-sodium diet and to remain vigilant for any signs of infection or relapse of symptoms. The nursing team emphasizes the importance of regular follow-up appointments to track progress and make any necessary adjustments to the treatment plan. With adherence to the medical and dietary regimen, the team is optimistic about sustaining the child's remission and preventing any further complications.

Section 4

During a routine follow-up appointment two weeks later, the nursing team conducts a comprehensive assessment of the child to evaluate the continued response to treatment for Nephrotic Syndrome. The child's overall appearance remains positive, with the mother reporting no significant changes in his condition since the last visit. During the physical examination, the nurse notes that the minimal ankle edema observed previously has resolved entirely, and the child’s skin remains healthy with good elasticity and no signs of dehydration. His energy levels are high, and he actively engages in conversations, displaying a cheerful demeanor.

The latest laboratory results further corroborate the positive clinical picture. The child's urine dipstick test now shows negative for proteinuria, indicating complete remission of this particular symptom. Serum albumin levels have increased slightly to 3.7 g/dL, a promising sign of improved protein retention and nutritional status. Additionally, his cholesterol level has further decreased to 200 mg/dL, suggesting that dietary modifications and the tapering of corticosteroids are being well-tolerated and effective. Vital signs remain stable, with a blood pressure of 104/64 mmHg and a heart rate of 74 beats per minute, indicating his cardiovascular status is being well-maintained.

Encouraged by the child's progress, the healthcare team discusses the next steps with the family. They decide to continue the gradual tapering of corticosteroids while emphasizing the importance of adherence to the low-sodium diet and regular physical activity to support long-term health. The family is reminded of the need to watch for any signs of relapse or infection, such as increased swelling, fatigue, or fever, and to seek medical attention promptly if these occur. The team schedules the next follow-up appointment in one month, with the goal of further reducing medication while maintaining the gains achieved in the child's recovery. This plan aims to support the child's ongoing remission and overall well-being, setting a solid foundation for his continued progress.

Section 5

During the next monthly follow-up appointment, the nursing team conducts a thorough assessment to ensure the child maintains his positive trajectory in managing Nephrotic Syndrome. The child's mother reports that he has continued to adhere to the low-sodium diet and remains active, enjoying outdoor play and participating in school activities without any issues. During the physical examination, the nurse observes that the child's weight is stable, and there is no evidence of edema, confirming the ongoing success of the treatment plan. His skin is still healthy, and he exhibits normal turgor, reflecting adequate hydration and good nutritional status. The child is alert, playful, and engages eagerly with the healthcare team, showcasing his sustained high energy levels.

Laboratory results from this visit reveal continued improvement. The urine dipstick test remains negative for proteinuria, and serum albumin levels have further increased to 4.0 g/dL, indicating robust protein synthesis and retention. The child's cholesterol level continues to decrease, now at 190 mg/dL, which is within the normal range and underscores the effectiveness of dietary management combined with the tapering of corticosteroids. Vital signs remain stable with a blood pressure of 102/66 mmHg and a heart rate of 72 beats per minute, reinforcing the positive impact of the current treatment regimen.

With these encouraging results, the healthcare team discusses the next steps with the family. They decide to continue tapering the corticosteroids carefully while maintaining the dietary and lifestyle modifications that have proven successful. The family is educated on the importance of vigilance for any signs of relapse, such as swelling or changes in energy levels, and the need for immediate evaluation if these symptoms arise. The next follow-up is scheduled for two months later, reflecting confidence in the child's current stability and progress, with the aim of further reducing medication dependency while ensuring sustained remission and well-being.